Repressor of GATA negatively regulates murine contact hypersensitivity through the inhibition of type-2 allergic responses

Clinical Immunology

Volumn 139, Issue 3, 2011, Pages 267-276

  Hirasaki, Yoshiro ^a   Iwamura, Chiaki ^a   Yamashita, Masakatsu ^a   Ito, Toshihiro ^a   Kitajima, Masayuki ^a   Shinoda, Kenta ^a   Namiki, Takao ^a   Terasawa, Katsutoshi ^a   Nakayama, Toshinori ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Contact hypersensitivity; Mast cell degranulation; Repressor of GATA (ROG); Th2 responses

Indexed keywords

HAPTEN; REPRESSOR OF GATA PROTEIN; TRANSCRIPTION FACTOR GATA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE EXACERBATION; INFLAMMATION; LUNG EDEMA; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWELLING; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; CELL DIFFERENTIATION; DERMATITIS, CONTACT; DISEASE MODELS, ANIMAL; HISTOCYTOCHEMISTRY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; REPRESSOR PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; TH2 CELLS;

EID: 79955954447     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.02.009     Document Type: Article

References (46)

1. Uter W., Ramsch C., Aberer W., Ayala F., Balato A., Beliauskiene A., Fortina A.B., Bircher A., Brasch J., Chowdhury M.M., Coenraads P.J., Schuttelaar M.L., Cooper S., Corradin M.T., Elsner P., English J.S., Fartasch M., Mahler V., Frosch P.J., Fuchs T., Gawkrodger D.J., Gimenez-Arnau A.M., Green C.M., Horne H.L., Jolanki R., King C.M., Krecisz B., Kiec-Swierczynska M., Ormerod A.D., Orton D.I., Peserico A., Rantanen T., Rustemeyer T., Sansom J.E., Simon D., Statham B.N., Wilkinson M., Schnuch A. The European baseline series in 10 European countries, 2005/2006-results of the European Surveillance System on Contact Allergies (ESSCA). Contact Dermat. 2009, 61:31-38.
2. Munoz Lejarazu D. Contact dermatitis: Alergologica-2005. J. Investig. Allergol. Clin. Immunol. 2009, 19(Suppl 2):34-36.
3. Keegel T., Moyle M., Dharmage S., Frowen K., Nixon R. The epidemiology of occupational contact dermatitis (1990-2007): a systematic review. Int. J. Dermatol. 2009, 48:571-578.
4. Burnett C.A., Lushniak B.D., McCarthy W., Kaufman J. Occupational dermatitis causing days away from work in U.S. private industry, 1993. Am. J. Ind. Med. 1998, 34:568-573.
5. Kalish R.S., Askenase P.W. Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity. J. Allergy Clin. Immunol. 1999, 103:192-199.
6. Wang B., Fujisawa H., Zhuang L., Freed I., Howell B.G., Shahid S., Shivji G.M., Mak T.W., Sauder D.N. CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 2000, 165:6783-6790.
7. Vocanson M., Hennino A., Rozieres A., Poyet G., Nicolas J.F. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 2009, 64:1699-1714.
8. Saint-Mezard P., Berard F., Dubois B., Kaiserlian D., Nicolas J.F. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur. J. Dermatol. 2004, 14:131-138.
9. Kehren J., Desvignes C., Krasteva M., Ducluzeau M.T., Assossou O., Horand F., Hahne M., Kagi D., Kaiserlian D., Nicolas J.F. Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J. Exp. Med. 1999, 189:779-786.
10. Grabbe S., Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Am. J. Contact Dermat. 1996, 7:238-246.
11. Akiba H., Kehren J., Ducluzeau M.T., Krasteva M., Horand F., Kaiserlian D., Kaneko F., Nicolas J.F. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J. Immunol. 2002, 168:3079-3087.
12. Yokozeki H., Wu M.H., Sumi K., Igawa K., Miyazaki Y., Katayama I., Takeda K., Akira S., Nishioka K. Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice. Clin. Exp. Immunol. 2003, 132:385-392.
13. Yokozeki H., Ghoreishi M., Takagawa S., Takayama K., Satoh T., Katayama I., Takeda K., Akira S., Nishioka K. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J. Exp. Med. 2000, 191:995-1004.
14. Schneider C., Docke W.D., Zollner T.M., Rose L. Chronic mouse model of TMA-induced contact hypersensitivity. J. Invest. Dermatol. 2009, 129:899-907.
15. Norman M.U., Hwang J., Hulliger S., Bonder C.S., Yamanouchi J., Santamaria P., Kubes P. Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response. Am. J. Pathol. 2008, 172:1638-1649.
16. K. Hosoya, T. Satoh, Y. Yamamoto, K. Saeki, K. Igawa, M. Okano, T. Moriya, O. Imamura, Y. Nemoto, H. Yokozeki, Gene silencing of STAT6 with siRNA ameliorates contact hypersensitivity and allergic rhinitis, Allergy 66 (2011) 124-131.
17. Dieli F., Sireci G., Scire E., Salerno A., Bellavia A. Impaired contact hypersensitivity to trinitrochlorobenzene in interleukin-4-deficient mice. Immunology 1999, 98:71-79.
18. Dearman R.J., Kimber I. Role of CD4(+) T helper 2-type cells in cutaneous inflammatory responses induced by fluorescein isothiocyanate. Immunology 2000, 101:442-451.
19. Adamson A.S., Collins K., Laurence A., O'Shea J.J. The Current STATus of lymphocyte signaling: new roles for old players. Curr. Opin. Immunol. 2009, 21:161-166.
20. Yamashita M., Ukai-Tadenuma M., Kimura M., Omori M., Inami M., Taniguchi M., Nakayama T. Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus. J. Biol. Chem. 2002, 277:42399-42408.
21. Schwenger G.T., Fournier R., Kok C.C., Mordvinov V.A., Yeoman D., Sanderson C.J. GATA-3 has dual regulatory functions in human interleukin-5 transcription. J. Biol. Chem. 2001, 276:48502-48509.
22. Santangelo S., Cousins D.J., Winkelmann N.E., Staynov D.Z. DNA methylation changes at human Th2 cytokine genes coincide with DNase I hypersensitive site formation during CD4(+) T cell differentiation. J. Immunol. 2002, 169:1893-1903.
23. Inami M., Yamashita M., Tenda Y., Hasegawa A., Kimura M., Hashimoto K., Seki N., Taniguchi M., Nakayama T. CD28 costimulation controls histone hyperacetylation of the interleukin 5 gene locus in developing th2 cells. J. Biol. Chem. 2004, 279:23123-23133.
24. Ansel K.M., Djuretic I., Tanasa B., Rao A. Regulation of Th2 differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 2006, 24:607-656.
25. Holloway J.W., Yang I.A., Holgate S.T. Genetics of allergic disease. J. Allergy Clin. Immunol. 2010, 125:S81-94.
26. Kelly K.F., Daniel J.M. POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol. 2006, 16:578-587.
27. Miaw S.C., Choi A., Yu E., Kishikawa H., Ho I.C. ROG, repressor of GATA, regulates the expression of cytokine genes. Immunity 2000, 12:323-333.
28. Yu D., Rao S., Tsai L.M., Lee S.K., He Y., Sutcliffe E.L., Srivastava M., Linterman M., Zheng L., Simpson N., Ellyard J.I., Parish I.A., Ma C.S., Li Q.J., Parish C.R., Mackay C.R., Vinuesa C.G. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 2009, 31:457-468.
29. Nurieva R.I., Chung Y., Martinez G.J., Yang X.O., Tanaka S., Matskevitch T.D., Wang Y.H., Dong C. Bcl6 mediates the development of T follicular helper cells. Science 2009, 325:1001-1005.
30. Johnston R.J., Poholek A.C., DiToro D., Yusuf I., Eto D., Barnett B., Dent A.L., Craft J., Crotty S. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 2009, 325:1006-1010.
31. Kovalovsky D., Uche O.U., Eladad S., Hobbs R.M., Yi W., Alonzo E., Chua K., Eidson M., Kim H.J., Im J.S., Pandolfi P.P., Sant'Angelo D.B. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 2008, 9:1055-1064.
32. Collins T., Stone J.R., Williams A.J. All in the family: the BTB/POZ, KRAB, and SCAN domains. Mol. Cell. Biol. 2001, 21:3609-3615.
33. Omori M., Yamashita M., Inami M., Ukai-Tadenuma M., Kimura M., Nigo Y., Hosokawa H., Hasegawa A., Taniguchi M., Nakayama T. CD8 T cell-specific downregulation of histone hyperacetylation and gene activation of the IL-4 gene locus by ROG, repressor of GATA. Immunity 2003, 19:281-294.
34. Hirahara K., Yamashita M., Iwamura C., Shinoda K., Hasegawa A., Yoshizawa H., Koseki H., Gejyo F., Nakayama T. Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyperresponsiveness. J. Allergy Clin. Immunol. 2008, 122:512-520. e11.
35. Kunisawa J., Kurashima Y., Higuchi M., Gohda M., Ishikawa I., Ogahara I., Kim N., Shimizu M., Kiyono H. Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium. J. Exp. Med. 2007, 204:2335-2348.
36. Desvignes C., Etchart N., Kehren J., Akiba I., Nicolas J.F., Kaiserlian D. Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells. J. Immunol. 2000, 164:2515-2522.
37. Yokozeki H., Wu M.H., Sumi K., Awad S., Satoh T., Katayama I., Takeda K., Akira S., Kaneda Y., Nishioka K. In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model. Gene Ther. 2004, 11:1753-1762.
38. Asero R., Riboldi P., Tedeschi A., Cugno M., Meroni P. Chronic urticaria: a disease at a crossroad between autoimmunity and coagulation. Autoimmun. Rev. 2007, 7:71-76.
39. Kawakami T., Kitaura J. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J. Immunol. 2005, 175:4167-4173.
40. Schwarz A., Grabbe S., Mahnke K., Riemann H., Luger T.A., Wysocka M., Trinchieri G., Schwarz T. Interleukin 12 breaks ultraviolet light induced immunosuppression by affecting CD8+ rather than CD4+ T cells. J. Invest. Dermatol. 1998, 110:272-276.
41. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., Sekikawa K., Asano M., Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17:375-387.
42. Larsen J.M., Bonefeld C.M., Poulsen S.S., Geisler C., Skov L. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis. J. Allergy Clin. Immunol. 2009, 123:486-492.
43. Iwakura Y., Nakae S., Saijo S., Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 2008, 226:57-79.
44. Bieber T. Atopic dermatitis. Ann. Dermatol. 2010, 22:125-137.
45. Hashizume H., Yagi H., Ohshima A., Ito T., Horibe N., Yoshinari Y., Takigawa M. Comparable risk of herpes simplex virus infection between topical treatments with tacrolimus and corticosteroids in adults with atopic dermatitis. Br. J. Dermatol. 2006, 154:1204-1206.
46. Langley R.G., Luger T.A., Cork M.J., Schneider D., Paul C. An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance. Dermatology 2007, 215(Suppl 1):27-44.